Author

Simeng Liu

University of PittsburghORCID 0009-0008-6865-1340Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Abdalla M. WedniD· 1 shared Adrian V. LeeiD· 1 shared Fangyuan CheniD· 1 shared Geoffrey L. PecariD· 1 shared Jagmohan HoodaiD· 1 shared Jennifer M. AtkinsoniD· 1 shared Steffi OesterreichiD· 1 shared Ye CaoiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abdalla M. WednORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintApr 4, 2025

Targeting RET in Brain Metastases from Estrogen Receptor Positive Breast Cancer

Simeng Liu, Geoffrey L. Pecar, Ye Cao…·Adrian V. Lee

This study identifies RET as a druggable target in estrogen receptor-positive breast cancer brain metastases and shows that Pralsetinib inhibits RET-driven metastatic properties.

DOI 10.1101/2025.04.04.647085

humanproteomics

𝕏 PostBluesky